When obtained through uncertified pharmacies, the quality and legitimacy of semaglutide cant be guaranteed
Health plans are working to balance access with affordability and appropriate use
Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial In TRIUMPH-1, participants on 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks with 45.3% of participants achieving 30% weight loss
If the dosage is different, the duration of use may also vary
Regular follow-up during dose titration enables timely intervention when problems arise
Sexual medicine reviews , 6(1), 4553